Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeated aluminum ingestion alters human intestinal structure: focus on advanced 3D tissue models.

Pflugers Archiv : European journal of physiology·2026
Same author

Development and validation of a knowledge-based model for robotic radiosurgery planning for brain lesions.

Physics and imaging in radiation oncology·2026
Same author

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

JCO precision oncology·2026
Same author

Functional Repurposing of Magnetic Nanoparticle-Assisted Hyperthermia for Immune Cell Labelling and Tracking.

Small methods·2026
Same author

Antitumor Activity of Liposomal Nanoparticles Co-Encapsulating Ceramides and Doxorubicin in In Vitro Nucleolin-Expressing Neuroblastoma Models.

Cells·2026
Same author

Seeing, Interpreting, and Trusting Images in the Age of Artificial Intelligence.

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society·2026

Related Experiment Video

Updated: Jun 13, 2025

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
10:09

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

6.8K

Exosomes and immune modulation: implications for neuroblastoma immunotherapy.

Martina Morini1, Chiara Vitale2, Martina Ardito1

  • 1Laboratory of Experimental Therapies in Oncology, IRCCS Istituto Giannina Gaslini, Genova, Italy.

Frontiers in Immunology
|June 11, 2025
PubMed
Summary

Tumor-derived exosomes (TDEs) suppress immune responses, hindering immunotherapy. Engineering exosomes, particularly from NK cells, offers a promising strategy to enhance anti-cancer immunity and improve treatment outcomes.

Keywords:
NK cellscancer stem cellsexosomesimmunotherapyneuroblastomatumor microenvironment

More Related Videos

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells
12:02

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells

Published on: November 11, 2021

4.1K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.0K

Related Experiment Videos

Last Updated: Jun 13, 2025

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment
10:09

Characterization of Immune Cell-derived Extracellular Vesicles and Studying Functional Impact on Cell Environment

Published on: June 2, 2020

6.8K
Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells
12:02

Isolation of Exosome-Enriched Extracellular Vesicles Carrying Granulocyte-Macrophage Colony-Stimulating Factor from Embryonic Stem Cells

Published on: November 11, 2021

4.1K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

25.0K

Area of Science:

  • Immunology
  • Cell Biology
  • Cancer Research

Background:

  • Exosomes are nano-sized vesicles crucial for cell communication and homeostasis.
  • Tumor-derived exosomes (TDEs) create an immunosuppressive tumor microenvironment (TME) by inhibiting immune cells like T and NK cells.
  • Cancer Stem Cell (CSC)-derived exosomes exacerbate immune suppression, impacting immunotherapy efficacy.

Purpose of the Study:

  • To review the complex interplay between TDEs and immune cells, focusing on NK cells.
  • To explore the role of TDEs and CSC-derived exosomes in immune evasion.
  • To discuss exosome-based therapeutic strategies for enhancing cancer immunotherapy.

Main Methods:

  • Literature review focusing on exosome function in cancer immunology.
  • Analysis of TDEs' impact on immune cell subsets (T cells, NK cells, dendritic cells).
  • Examination of engineered NK cell-derived exosomes for therapeutic potential.

Main Results:

  • TDEs actively suppress anti-tumor immunity by inhibiting key immune cell functions.
  • Blocking TDE release or uptake is a potential strategy to improve immunotherapy.
  • Engineered exosomes, especially from NK cells, can be utilized to stimulate anti-cancer immune responses.

Conclusions:

  • Exosomes play a dual role in cancer, promoting immune suppression via TDEs and offering therapeutic avenues via engineered exosomes.
  • Targeting TDEs and leveraging NK cell-derived exosomes are promising strategies to overcome immunotherapy resistance.
  • Further research into exosome-based therapies, particularly in neuroblastoma, is warranted to improve cancer treatment.